Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Larynx Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02035527
What this trial is testing

Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+34 more
Ohio State University Comprehensive Cancer Center 3
Large-scale testing (Phase 3)Study completedNCT00608205
What this trial is testing

Radiation Therapy Cisplatin With or Without Fluorouracil Patients With Stage III or Stage IV Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Case Comprehensive Cancer Center 69
Testing effectiveness (Phase 2)Ended earlyNCT00592319
What this trial is testing

Celebrex (Celecoxib) Treatment of Laryngeal Papilloma

Who this might be right for
Laryngeal Papilloma
Boston University 10
Testing effectiveness (Phase 2)WithdrawnNCT06084845
What this trial is testing

Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaHypopharyngeal Squamous Cell CarcinomaLaryngeal Squamous Cell Carcinoma+12 more
ECOG-ACRIN Cancer Research Group
Not applicableWithdrawnNCT05512767
What this trial is testing

A Pneumatic Compression Device for the Treatment of Lymphedema in Patients With Stage II-IV Head and Neck Cancer After Chemoradiation

Who this might be right for
Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal CarcinomaClinical Stage III HPV-Mediated (p16-pos) Oropharyngeal CarcinomaClinical Stage IV HPV-Mediated (p16-pos)Oropharyngeal Carcinoma+13 more
Mayo Clinic
Early research (Phase 1)Study completedNCT00576134
What this trial is testing

The Objective is to Respond to Patients' Needs in the Field of Larynx Replacement

Who this might be right for
Swallowing DisordersDysphagiaLaryngeal Neoplasms
University Hospital, Strasbourg, France 10
Not applicableStudy completedNCT05217147
What this trial is testing

An Investigation of Biomarker Candidate Molecules in Laryngeal Carcinoma

Who this might be right for
Larynx CancerLarynx Carcinoma
Hacettepe University 80
Very early researchLooking for participantsNCT06914999
What this trial is testing

Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer

Who this might be right for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+13 more
Emory University
Testing effectiveness (Phase 2)Study completedNCT05199584
What this trial is testing

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

Who this might be right for
Solid Tumors With PTCH1 Loss-of-function Mutations
Endeavor Biomedicines, Inc. 20
Not applicableStudy completedNCT03656133
What this trial is testing

Use of a Proliferation Saturation Index to Determine Personalized Radiotherapy for HPV + Oropharyngeal Cancers

Who this might be right for
Oropharyngeal Cancer
H. Lee Moffitt Cancer Center and Research Institute 55
Post-approval studies (Phase 4)Study completedNCT03461328
What this trial is testing

Effect of Magnesium Sulphate Infusion on Lung Mechanics and Oxygenation in COPD Patients Undergoing Total Laryngeal

Who this might be right for
Chronic Obstructive Pulmonary Diseases
Cairo University 40
Testing effectiveness (Phase 2)Study completedNCT00765011
What this trial is testing

TPF Plus Radiotherapy and Cetuximab to Avoid Total Laryngectomy in Patients With Larynx Cancer

Who this might be right for
Head and Neck Cancer
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello 94
Not applicableStudy completedNCT00001167
What this trial is testing

Ultrasound Evaluation of Tongue Movements in Speech and Swallowing

Who this might be right for
Otorhinolaryngologic DiseaseOtorhinolaryngologic NeoplasmPharyngeal Neoplasm+2 more
National Institutes of Health Clinical Center (CC) 570
Testing effectiveness (Phase 2)Active Not RecruitingNCT03854032
What this trial is testing

Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck

Who this might be right for
LipOral Cavity Squamous Cell CarcinomaPharynx+2 more
Thomas Jefferson University 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06894459
What this trial is testing

A Prospective, Multicenter, Multicohort Phase II Study: Evaluating the Efficacy and Safety of Preoperative Neoadjuvant Treatment With a PD-1 Inhibitor in Combination With Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancers
Beijing Tongren Hospital 180
Early research (Phase 1)Active Not RecruitingNCT02567422
What this trial is testing

Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Cancer

Who this might be right for
Head and Neck Carcinoma of Unknown PrimaryHead and Neck Squamous Cell CarcinomaStage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7+9 more
National Cancer Institute (NCI) 43
Large-scale testing (Phase 3)Study completedNCT00095875
What this trial is testing

Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial)

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 145
Testing effectiveness (Phase 2)Looking for participantsNCT06611137
What this trial is testing

SBRT Followed by Chemoimmunotherapy of Toripalimab Plus Docetaxel and Cisplatin for Larynx Preservation in Patients with Locally Regionally Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx

Who this might be right for
Laryngeal CancerHypopharynx Cancer
Sun Yat-sen University 35
Testing effectiveness (Phase 2)Ended earlyNCT01219673
What this trial is testing

Symptom Burden in Head and Neck Cancer

Who this might be right for
Head And Neck Cancer
M.D. Anderson Cancer Center 1
Early research (Phase 1)Ended earlyNCT01528137
What this trial is testing

Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+43 more
Stanford University 4
Next Page
20